CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us
  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading
Top Therapeutics Companies Top Cancer Destroying Platform - 2025 Next-generation Oncology Company of the Year - 2025 Top Regenerative Medicine Solutions Providers - 2024 Top Exosome Therapeutics Company - 2024 Top Therapeutics Companies - 2022 Top Emerging Therapeutics Companies - 2022

Life Sciences Review

Therapeutics

Historical Control In Gene Therapy Clinical Development

Historical Control In Gene Therapy Clinical Development

Haichen Yang

MD, MA, MBA, Vice President

Amicus Therapeutics Inc [NASDAQ: FOLD]

Precision Immunology Therapy

Setting a New Standard in Precision Immunology

Reginald Seeto

CEO

Scipher Medicine

Featured Issue
PreviousNext

Featured Categories

Precision Immunology Therapy

GABA Disorders Treatment

#

Insights into the Emerging Trends in Life Sciences

Claudia Casalino, Corporate Compliance Manager Alfasigma
#

The New Age of Patient Treatment

Kashif Zuberi, Laparoendoscopic Gastrointestinal Surgeon at Sanford Health
#

Gaba Disorders Treatment

Restoring Balance to the Brain’s Most Fragile Chemistry

Dr. Alexander Rotenberg, Co-Founder, Dr. Henry Lee, Co-Founder Galibra Neuroscience
#

Tissue Regeneration Solution

Transforming Osteoarthritis Treatment from Crisis to Cure

Dr. Siddhesh Angle, Founder and CEO Regenosine
Historical Control In Gene Therapy Clinical Development

Historical Control In Gene Therapy Clinical Development

Haichen Yang, MD, MA, MBA, Vice President

Amicus Therapeutics Inc [NASDAQ: FOLD]

OncoHost: A Holistic Approach to Personalizing Cancer Treatment

A Holistic Approach to Personalizing Cancer Treatment

Dr. Ofer Sharon, MD and CEO

OncoHost

#

Rewriting the Oncology Playbook

John V. Oyler, Co-Founder, Chairman & CEO

BeOne

News

Clinical Trial Management Moves Toward A More Connected Model

Biomarker Claims Face Evidence Test

Choosing an ADC and AOC CDMO Partner for Complex Bioconjugates

Biomarker Results Leave Decisions Open

Potential of Cell and Gene Therapy

Potential of Cell and Gene Therapy

Kathy Van Sickle, Director, Preclinical ADME and PK, Neuroscience

Bristol Myers Squibb

Cognitive-Behavioral Therapy for Anxiety Disorders

Cognitive-Behavioral Therapy for Anxiety Disorders

David F. Tolin, Ph.D., Director, Anxiety Disorders Center and Center for Cognitive Behavioral Therapy, Institute of Living

Hartford Hospital

Nielsen BioSciences: Immunotherapy targeting the Underlying Cause of Warts

Immunotherapy Company

Immunotherapy targeting the Underlying Cause of Warts

Christoph Wulf, Vice President Commercial

Nielsen BioSciences

CellTrans Inc: A Turning Point in Diabetes Treatment with Islet Cell Therapy

Diabetes Cell Therapy

A Turning Point in Diabetes Treatment with Islet Cell Therapy

José Oberholzer, Founder and President, CMO

CellTrans Inc

Loading...
#

Tapping the Power of Oligonucleotides for Therapeutics

Matthias Schroff, CEO, Exicure

#

A Better Life for Cancer Patients

Michael Bailey, CEO, AVEO Oncology

#

Shaping A New Paradigm in Research and Therapeutics

Chris E. Rivera, CEO, President, and Chairman, EMulate Therapeutics

#

Taking Regenerative Medicine to the Next Generation

Tina Kotulski, CFO, Between the Bridges Healing Center

A Regenerative Pathway to Improving Long-Term Outcomes

A Regenerative Pathway to Improving Long-Term Outcomes

Richard J. McMurtrey, MD, MSc – Chief Medical Officer/Medical Director, Alpine Spine & Orthopedics Institute

Leading the Charge in Orthopedic Rehabilitation with Regenerative Medicine

Leading the Charge in Orthopedic Rehabilitation with Regenerative Medicine

Dr. Matthew Kohler, Founder, Ospina Medical

#

Non-Surgical Approaches to Musculoskeletal Self-Healing

David Harris, MD, Owner, Center for Healing and Regenerative Medicine

News

Advancements in iPSC Technology: Enhancing Precision Medicine and Therapeutics

Future Medicine: Autologous Tissue Engineering Driving Clinical Progress

Integrating Multi-Omics Data with AI for Advanced RNA Therapeutic Development

Therapeutics Innovation Reshapes the Future of Modern Healthcare

Novel Treatments for Musculoskeletal Conditions through Regenerative Medicine

Novel Treatments for Musculoskeletal Conditions through Regenerative Medicine

Joshua A. Carr, Owner, Coral Canyon Joint & Spine Health

Pioneering Regenerative Medicine through Innovation and Education

Pioneering Regenerative Medicine through Innovation and Education

Jason Francis, Co-Founder, Global Regenerative Group

Your Path to Regenerative Wellness at Home

Your Path to Regenerative Wellness at Home

Elliot Campbell, Founder and President, RegenMD

The Msc Exosome Production and Isolation Leader

The Msc Exosome Production and Isolation Leader

Duncan Ross, PH.D., Founder and CEO, Kimera Labs

#

Cancer Destroying Platform

“One-Shot” Cure for Deadly Cancers

Dr. Nanhai George Chen, CEO, ViroMissile

#

New Impella 5.5 Heart Pump Device Provides Potentially Life-Saving Treatment Option for Patients with Cardiogenic Shock

Mark Anderson, M.D., Chief of the Division of Cardiac Surgery and Cardiothoracic Surgeon at the Heart and Vascular Hospital at Hackensack University Medical Center and Hackensack Meridian Health.

#

Soli Organic's Recipe For Affordable, Indoor Organic Produce: The Right Blend Of Tech + Nature

Gianna De Caro, Chief Product Officer, Soli Organic

#

Scaling The Future Of Sustainable Food Through Fermentation

Frances Gilman, Senior Manager of R&D, Next Generation Ingredients, Kraft Heinz

Connecting Science And Strategy To Drive Innovation Forward

Connecting Science And Strategy To Drive Innovation Forward

Martina Miteva, Director, Product Owner, Research Business Insights and Technology, Bristol Myers Squibb

Operational Leadership that Keeps People at the Center

Operational Leadership that Keeps People at the Center

Ryan Garland, AVP - Radiology & Respiratory, Endeavor Health

#

Navigating the U.S. Immigration System

Julia Fernandez Cocimano, Director Mobility, Immigration & Talent Programs, Altos Labs

News

AI-Based Prognostics: Enhancing Operational Efficiency Across Sectors

Tissue Dissociation's Expanding Role in Translational Medicine

PEG Linkers and the Chemistry Behind Smarter Therapies

The Explosive Growth of Immunotherapeutic Innovations
Why Accreditation Matters

Why Accreditation Matters

Will Roden, Administrative Director of Cardiovascular Services/Practice Administrator, Augusta Health

Transforming Quantitative Sciences and Reporting With Real-World Data

Transforming Quantitative Sciences and Reporting With Real-World Data

Lothar Tremmel, Vice President, QCSR (Biometrics + Epidemiology), CSL Behring

Challenges, Trends, and Strategies in Modern Healthcare - Light Therapy

Challenges, Trends, and Strategies in Modern Healthcare - Light Therapy

Ryan Garland, MHA BS RT(R), AVP- South Region Radiology & Respiratory, Endeavor Health

Driving Excellence in Structural Heart Therapy

Driving Excellence in Structural Heart Therapy

Dr. Gilbert Tang, Academic Director, Structural Heart Program, Mount Sinai Health System

Thank you for Subscribing to Life Science Review Weekly Brief

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://therapeutics.lifesciencesreview.com